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Abstract: There continues to be a need for improved medical management of diabetes patients 
with hypertension in primary care. While several care models have shown effectiveness in 
achieving various outcomes among these patients, it remains unclear what care model is 
most effective in improving blood pressure control in primary care. In this prospective study, 
54 patients with type 2 diabetes mellitus and blood pressure of 140/90 identified through the 
registry, were randomized into three groups. Group A attended a nurse educator-conducted 
class on diabetes and hypertension, group B attended the same class and was asked to monitor 
their home blood pressure using provided device, and group C served as control (usual care). 
Of the 24 subjects who completed the study, only 20% achieved the target blood pressure of 
130/80 and there was no statistical difference in mean systolic and diastolic blood pressures 
among the three groups (p  0.05). Efforts to intensify management of hypertension among 
type 2 diabetes patients did not result in better blood pressure control compared to usual care. 
Studies looking into factors which limit patients’ participation in group classes and determining 
patients’ preferences in disease management would be helpful in ensuring success of any chronic 
disease management program.
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Background
Cardiovascular disease is the leading cause of premature mortality among patients with 
diabetes, with heart disease accounting for more than half of these deaths. Hypertension 
is common in patients with type 2 diabetes, with a prevalence of 40%–60% over the 
age range of 45 to 75 and contributes to their risk of cardiovascular disease.1 The 
association of elevated blood pressure with risk is amplified in patients with diabetes 
who have roughly a doubling of absolute risk compared with patients without diabetes 
at each systolic blood pressure level.
Several trials have documented the importance of blood pressure control in reducing 
the risk of cardiovascular and renal disease among patients with diabetes.2–5 Results of 
these trials supported an aggressive approach to the treatment of hypertension among 
patients with diabetes leading to a recommended blood pressure goal of 130/80.5–7 
This requires the use of at least two agents in most patients with the consensus of 
having a renin–angiotensin system blocker as first-line treatment.6–8
Effective control of blood pressure among patients with diabetes continues to 
pose a clinical practice challenge. Hypertensive diabetes patients are still frequently 
not treated to their goal blood pressure; studies demonstrated that this group of 
patients has worse blood pressure control than patients with hypertension but without Vascular Health and Risk Management 2009:5 706
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diabetes mellitus.9,10 Clinical uncertainty about the true 
blood pressure value was a major reason identified as to why 
providers do not intensify antihypertensive therapy among 
diabetes patients.11 Clearly, there is room for outpatient 
practice improvement.
Several care models have been shown to be effective 
at improving outcomes among diabetes patients. Group 
education classes have been successful in enhancing diabetes 
care.12,13 A case study reported achievement of blood pressure 
control in majority of patients with diabetes secondary to 
nursing staff involvement in care management and use of 
medications concomitant with guidelines.14 Another study 
found that a nurse-led hypertension clinic was more effective 
for patients with type 2 diabetes and uncontrolled hypertension 
compared to conventional care.15 It is unclear which of these 
models is most effective in achieving hypertension control 
among diabetes patients in a primary care setting.
In the recent years, the SHEAF trial and other studies 
have thrown another complexity into hypertension control by 
showing that office blood pressure readings were inaccurate 
in 22% of treated hypertensive patients. Subsequent studies 
showed that use of home blood pressure measurement by 
a physician/nurse team has the potential to significantly 
improve long-term hypertension control rates and that 
self-monitoring of blood pressure promoted achievement 
of target blood pressure in primary health care.16,17 One 
study even showed ambulatory blood pressure to be a better 
marker than clinic blood pressure in predicting cardiovascular 
events in patients with or without type 2 diabetes.18 Thus, 
self-monitored or home blood pressure measurement is 
becoming a potentially very powerful and cost-effective tool 
in the management of hypertension.
Disease registries are powerful tools that allow identi-
fication of high-risk patients within a defined population.19 
A previously published study utilized the diabetes registry 
to evaluate implementation strategies aimed at improving 
glycosylated hemoglobin and low-density lipoprotein testing 
rates among poorly controlled diabetes patients.20
Using the diabetes registry to identify diabetes patients 
with hypertension who meet our target population, we 
conducted a study to compare three practice care models, 
two using intensified management and one using usual care, 
with the aim of achieving target blood pressure as recom-
mended by current practice guidelines. We hypothesized 
that (1) participation of diabetes patients with uncontrolled 
blood pressure (blood pressure 140/90) in an intensi-
fied care management model using a specific intervention 
would result in improved blood pressure control among 
this group of patients compared to conventional care, that 
(2) the percentage of diabetes patients with uncontrolled 
hypertension achieving target blood pressure readings (blood 
pressure 130/80) will be significantly higher among those 
randomized to an intensified model compared to conventional 
care, and that (3) different care delivery models would lead 
to varying degrees of blood pressure improvement among 
diabetes patients with uncontrolled hypertension.
Methods
Design
This was a prospective randomized control trial conducted 
in a multispecialty clinic in the midwestern United States. 
Eligible subjects were primary care paneled patients with 
diabetes mellitus type 2 and blood pressure above determined 
cut-off who were identified using the diabetes registry. 
Nursing home patients were excluded. Study duration was six 
months. The study protocol was approved by the Institutional 
Review Board.
Registry tool
The registry is an institutionally developed centralized 
database of diabetes patients who were identified based 
on administrative billing data that used International 
Classification of Diseases 9th revision codes (ICD-9 CM) for 
the diagnosis of diabetes. Provider patient lists are pulled from 
the clinic’s generalized patient appointment system, which 
identifies a patient’s primary care provider. Before being 
included in the registry, all patient records were reviewed 
by a registered nurse to verify that they are diabetics and are 
assigned to the correct physician. The registry is interfaced 
with other clinical information systems which allow entry of 
patient data such as blood pressure and laboratory test results. 
Blood pressure data are captured and updated weekly from 
the electronic medical record (EMR). It became available to 
providers beginning in early 2000.
Blood pressure cut-off
To determine the blood pressure threshold for identification 
of our target population from the diabetes registry, we did 
a retrospective analysis of three separate blood pressure 
readings in three groups of 20 randomly selected patients 
using targets of 130/80, 140/90, and 150/90. Using 130/80 
as cut-off, 100% of 20 patients had blood pressure of greater 
than 130/80 with one reading but only 45% was consistently 
above target with two out of three readings. At a cut-off 
of 140/90, 50% were consistently above target with two 
readings. With 150/90 as cut-off, 100% was above it at Vascular Health and Risk Management 2009:5 707
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first reading and 65% was still above target in two of three 
readings. However, this group constitutes less than a third 
of patients in the registry with above target blood pressure. 
We therefore selected to use a cut-off of 140/90 as at least 
50% of the 60 randomly selected diabetes patients in the 
registry were consistently above this target in two out of 
three readings.
Intervention
Four hundred ten patients qualified and were sent a letter 
of invitation to participate. There were 197 responders of 
whom 143 refused to participate and only 54 consented 
(Figure 1). After stratification based on gender, age (60 years, 
60 years) and hemoglobin A1C level (7%, 7%), each 
of the participant was randomized to one of three groups 
with two arms using practice care models and the third arm 
serving as control group. Group A patients were invited to 
participate in a class focusing on hypertension in diabetes. 
Group B patients were also invited to participate in the 
class; in addition, they were given automated blood pressure 
devices and asked to track their home blood pressure readings 
and record them in a booklet to be submitted at the end of 
the study. Three classes were set up to allow for flexibility in 
scheduling and each participant in the two groups was asked 
to attend one class. The classes were conducted by a diabetes 
nurse educator using structured format. The automated blood 
pressure device (Life Source UA-767 Plus; Life Source, San 
Jose, CA, USA) had been clinically validated according to 
British Hypertension Society (BHS) standards and had met 
the limits set by the American National Standards Institute. 
Group C patients did not receive any invitation. All study 
participants continued to see their primary care physicians 
for usual care. No interim follow-up was done during the 
study period. Since the study focused on comparing practice 
models, participants’ use of pharmacologic therapy for blood 
pressure control was not captured.
Seventeen patients were randomized to group A, 19 to 
group B, and 18 to group C.
Group A and B subjects had their blood pressure checked 
by a registered nurse (MH) during class attendance using 
standardized blood pressure measurement protocol used 
in the clinic (copy available upon request). Clinic blood 
pressure readings correlate closely with registry data. 
Those in group B received additional instruction on home 
blood pressure monitoring from the registered nurse based on 
the clinic’s patient education pamphlet entitled “Measuring 
Your Blood Pressure at Home” (MC3031-03). A copy of the 
pamphlet was also provided. All study participants were asked 
to return for a nurse blood pressure recheck after six months, 
again following the standardized blood pressure measurement 
protocol. Group B patients were also asked to bring back 
their booklet with home blood pressure readings.
Primary outcome measure was the percentage of study 
subjects who achieved blood pressure goal of 130/80 within 
six months as measured in clinic during the return visit. 
Secondary outcome measures were mean arterial pressures 
of participants in each study arm, and number of nurse (RN) 
and physician (MD) visits for each patient in each group.
Statistical method
Mean ± standard deviation (SD) for continuous variable 
or frequency (percentage %) for categorical variable was 
compared among the three groups using one-way analysis 
of variance (ANOVA) or Pearson’s chi-squared test, 
respectively. Post hoc pair-wise comparisons were applied 
using the Scheffe’s significant criteria.21 Table 1 was prepared 
using all available data with intention-to-treat analysis while 
Table 3 showed data only on those who had completed the 
study. Multivariate logistic model approach was also used 
to find possible factors that predicted achievement of target 
blood pressure goals. The analysis was performed using 
Total 410 eligible patients
143 declined to participate
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Figure 1 Flowchart of study population.Vascular Health and Risk Management 2009:5 708
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intent-to-treat and per protocol approaches. Participants who 
did not complete the entire six-month study period or failed 
to return at six-month follow-up were considered dropouts 
and were excluded in the per protocol analysis, but included 
in the intent-to-treat analysis.
When sample size is 18 in each group, we would have 
80% power to detect at the 0.050 level an effect size of 0.1893 
using one-way ANOVA. With the same sample size, a 0.050 
level Pearson’s chi-squared test will have 80% power to 
detect an odds ratio of 9.4 in proportions. All analyses were 
handled by SAS software (version 9.1.3; SAS institute, Cary, 
NC, USA). Any three-group comparison p-value less than 
0.05 was considered as statistically significant.
Results
Of the 410 eligible patients who were invited to participate, 
143 (34.9%) declined participation and 54 (13.2%) 
consented. There were 213 (52.0%) nonresponders. We did 












  Unknown 213 (52%) 212 (100%) 1 (1%) 0 (0%) 0 (0%)
  Female 104 (25%) N/A 76 (53%) 28 (52%) 10 (42%)
  Male 93 (23%) 1 (0%) 66 (46%) 26 (48%) 14 (58%)
p = 0.87* p = 0.18#
Age
  Unknown 356 (87%) 213 (100%) 143 (100%) 0 (0%) 0 (0%)
  Age  60 13 (3%) N/A 0 (0%) 13 (24%) 4 (17%)
  Age  60 41 (10%) N/A 0 (0%) 41 (76%) 20 (83%)
State
  Unknown 1 (0%) 1 (0%) 0 (0%) 0 (0%) 0 (0%)
  MN 400 (98%) 206 (97%) 141 (99%) 53 (98%) 24 (100%)
  Others 9 (2%) 6 (3%) 2 (1%) 1 (2%) 0 (0%)
p = 0.85* p = 0.37#
HBA1c  7%
  Unknown 356 (87%) 213 (100%) 143 (100%)
  No 32 (8%) N/A N/A 32 (59%) 15 (63%)
  Yes 22 (5%) N/A N/A 22 (41%) 9 (38%)
p = 0.66#
Notes: *Pearson’s chi-squared (compare participant vs nonparticipant combined); #Pearson’s chi-squared (compare completed vs noncompleted).
Abbreviations:
Table 1 Intention-to-treat analyses
Variable # A B C P-value
(N = 17) (N = 19) (N = 18)
Systolic pressure at baseline 54 152.41 ±8.09 148.26 ±6.81 148.44 ±7.72 0.19*
Diastolic pressure at baseline 54 73.35 ±8.86 71.95 ±14.19 73.5 ±12.26 0.91*
Systolic pressure at six months 54 152.76 ±11.91 147.05 ±13.87 143.28 ±13.64 0.11*
Diastolic pressure at six months 54 73.88 ±12.04 74.05 ±13.77 72 ±12.33 0.87*
Systolic: difference from baseline 54 0.35 ±15.04 -1.21 ±11.08 -5.17 ±11.23 0.41*
Diastolic: difference from baseline 54 0.53 ±8.94 2.11 ±6.90 -1.5 ±10.25 0.46*
SBP  130 and DBP  80, No. (%) 54 1 -6% 2 (11%) 1 6% 0.81#
Notes: *One-way   ANOVA, p-value; #Pearson’s chi-squared, p-value.
Abbreviations: DBP, diastolic blood pressure; SBP, systolic blood pressure.Vascular Health and Risk Management 2009:5 709
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not have gender and age information for the nonresponders 
as well as age information for nonparticipants. Gender was 
not different between those who consented to participate 
and the decliners (p = 0.87). The state where the patients 
lived were not different among participants, decliners, and 
nonresponders (p = 0.95). The participants however had 
slightly lower systolic and diastolic blood pressures than 
others (p = 0.03 and p = 0.06, respectively).
Twenty-eight (52%) of the 54 participants are female; 
41 (76%) are aged over 60 years and 22 (41%) have 
hemoglobin A1C level above 7% (Table 2). From the registry, 
study participants had a mean systolic blood pressure of 
149.79 and a mean diastolic blood pressure of 73.89. There 
was no difference in baseline mean systolic and diastolic 
blood pressure among the three groups. Seven patients 
randomized to group A attended the class; only five returned 
after six months for blood pressure recheck. Ten patients 
in group B attended the class and took home an automated 
blood pressure device; seven returned after six months. 
Of the 18 patients randomized to Group C, 12 returned, one 
died, and two were too ill to leave home (Figure 1).
After six months, only 20% (n = 5) of the 24 subjects 
who completed the study achieved the target blood pressure 
of 130/80. There was no difference in the percentage of 
subjects achieving target blood pressure among the three 
groups (p  0.05). Using both intention-to treat and per 
protocol analyses, there was no significant difference in 
mean systolic and diastolic blood pressures among the three 
groups of study participants after six months (Tables 1, 3). 
Interestingly, those in groups B and C had lower mean 
systolic and diastolic blood pressure than those in group A; 
however they are still not significant. Seven participants in 
group B returned their booklet with home blood pressure 
recordings at the end of the study period. There was variation 
in the number of home blood pressure readings among the 
seven participants with total readings ranging from 38 to 156. 
The mean systolic and diastolic home blood pressure readings 
in five of the seven participants was 130/80.
We compared the number of RN and MD visits during 
the study period for each study participant and found no 
difference among the three groups. We did not find any 
significant factor, using the multivariate logistic model 
that predicted achievement of target blood pressure goal. 
We considered each participant’s baseline systolic blood 
pressure, baseline diastolic blood pressure, BMI, RN, and 
MD visits.
Discussion
In this study, only 10% of randomized subjects (n = 54) 
with uncontrolled hypertension and diabetes achieved the 
target blood pressure of 130/60 after six months. Our study 
failed to show a statistical difference in mean blood pressure 
readings after six months among the subjects randomized into 
three study groups. Those randomized into a more intensive 
management; ie, groups A and B did not have significant 
improvement in blood pressure control compared to those 
under usual care. Different care delivery models (usual care 
plus education, usual care plus education and home blood 
pressure self monitoring, or usual care alone) did not result 
in varying degrees of blood pressure improvement among 
diabetes patients with uncontrolled hypertension. Given our 
small sample size, it was not surprising to see no statistically 
significant differences among the study groups. We were also 
underpowered as only half of the randomized participants 
completed the study.
Seven out of the 19 participants who were randomized to 
group B returned after six months with recorded home blood 
pressure readings, five subjects had mean blood pressure 
readings below 130/80. Outcome blood pressure readings 
in this study were obtained during a return clinic visit using 
standard protocol. Only two study participants in group B 
met target pressure on return clinic blood pressure check. 
Table 3 Per protocol analyses (subjects who completed the study)
Variable # A B C P-value
(n = 5) (n = 7) (n = 12)
Systolic pressure at baseline 24 156 ±11.66 145.43 ±5.26 149.17 ±6.98 0.09*
Diastolic pressure at baseline 24 78.8 ±2.68 68.43 ±11.60 73.92 ±13.83 0.34*
Systolic pressure at six months 24 157.2 ±20.73 142.14 ±20.88 141.42 ±15.31 0.26*
Diastolic pressure at six months 24 80.6 ±15.66 74.14 ±11.05 71.67 ±13.93 0.48*
Systolic: difference from baseline 24 1.2 ±30.06 -3.29 ±18.98 -7.75 ±13.15 0.67*
Diastolic: difference from baseline 24 1.8 ±17.80 5.71 ±10.90 -2.25 ±12.67 0.46*
Notes: *One-way ANOVA, p-value; #Pearson’s chi-squared p-value.Vascular Health and Risk Management 2009:5 710
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This observation is consistent with previously reported 
discrepancies between office and home blood pressure 
readings, home or ambulatory readings potentially being 
more accurate. Evaluating the achievement of recommended 
blood pressure among diabetics with uncontrolled hyper-
tension through different delivery care models using home 
blood pressure recordings may therefore be a more effective 
outcome measure.
Self-management is an essential component of chronic 
disease model. We failed to see a trend towards increased 
self-activation among participants in the practice model 
arms. Participation in education and tracking blood pressure 
readings at home did not increase patient’s likelihood of 
seeing a health care provider more often than those under 
conventional care. A characteristic defined as “I can take 
charge” and reflected in an individual’s proactive behavior 
of seeking more information from health care providers 
has been equated with high self-efficacy and adherence 
to medication.22 In this study, we incorporated chronic 
disease model components such as use of registry and allied 
professionals to achieve our stated aim.23 It was apparent 
that without the component of patient self-management, 
attainment of target blood pressure would be difficult. Indeed, 
evidence has supported the effectiveness of self-management 
training in diabetes care.24,25
We are not aware of any previously reported study that 
has compared blood pressure control among patients with 
diabetes mellitus and uncontrolled hypertension who were 
identified through the registry and randomized into different 
delivery care models. Despite its negative outcome, our study 
is the first of such kind. Our study was limited by its lack of 
power due to a small sample size and short follow-up of six 
months. We would recommend redesigning a larger study 
with a longer follow-up duration based on our experience 
in this pilot study.
As we continue to be challenged on how to best manage 
our patients with chronic diseases in the changing health 
care environment and patient population profile, there 
remains a great need to create innovative practice models. 
Given our study results, the next step perhaps is to focus 
on identifying factors that create barriers to patients’ 
participation into care initiatives and surveying patients 
regarding their preferences in care delivery and disease 
management. Valuable data can then be obtained that may 
help guide educators and practitioners into structuring a 
practice care model that enhances patients’ engagement 
in their health and deliver efficient care with sustained 
outcomes.
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